RxDoctor Payments Data

Eric Cornidez, MD

Pain Medicine · Tucson, AZNPI 1679792527

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $339,234 of the $495,694 with a category attached, or 68.4%. 45 manufacturers reported payments, led by Nalu Medical, Inc. at 33.2% of the total. 2025 is the largest year on record at $236,245, more than ten times the $20,782 reported in 2019. Among pain medicine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$495,694in general payments, 2019–2025

Across 1,619 payments — averaging $306.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nalu Medical, Inc.$165K
  • Saluda Medical Americas, Inc.$150K
  • Abbott$108K
  • Nevro Corp.$23K
  • Globus Medical$19K
  • Boston Scientific$14K
  • plus $18K from 39 others
$86,076in research payments, 2019–2025

Across 51 payments — averaging $1687.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$84K
  • Nevro Corp.$2K

What the payments were for

  • Consulting fees$339,23468%
  • Speaking & faculty fees$57,49812%
  • Travel & lodging$55,29711%
  • Food & beverage$43,6499%
  • Education$40%
  • Entertainment$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$495,694 in reported general payments places this provider in the 95th percentile of 180 pain medicine providers in Arizona.

See all pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$658,947
Medicare patients
922
Services billed
13,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl12$5,278
Pregabalin35$1,722
Gabapentin110$1,437
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen63$1,073
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$862
Duloxetine Hcl30$844
Oxycodone Hcl47$741
Morphine Sulfate ErMorphine Sulfate14$420
Methocarbamol19$373
Tizanidine Hcl31$282
Tramadol Hcl33$241
Meloxicam62$195
Ibuprofen22$114
Cyclobenzaprine Hcl13$91
Alprazolam20$16

Paid to pharmacies, not to this prescriber.

Other pain medicine in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →